Last viewed:
ANIX
Prices are updated after-hours
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
(0.0% 1d)
(-11.9% 1m)
(-35.6% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(-21.03%
volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 98,410,883
http://www.anixa.com
Sec
Filling
|
Patents
| 8 employees
(US) Anixa Biosciences, Inc. is a cancer-focused biotechnology company, which focuses on harnessing the body’s immune system in the fight against cancer. It operates through the following segments: Cancer Diagnostics, Cancer Therapeutics, and Legacy Patent Licensing Activities. Cancer Diagnostic segment develops CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body’s immune response to the presence of a malignancy. Cancer Therapeutics segment offers chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient’s own immune cells to fight cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
cancer
immunotherapy
car-t
t-cell
genetic
diagnostics
ceiling
add to watch list
Paper trade
email alert is off
Press-releases
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Published: 2024-03-14
(Crawled : 13:30)
- biospace.com/
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
| -0.31%
| O: -0.94%
H: 1.9%
C: -2.22%
presentation
meeting
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Published: 2024-03-11
(Crawled : 17:00)
- biospace.com/
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
| -2.46%
| O: -1.23%
H: 2.18%
C: 0.62%
vaccine
congress
world
presentation
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
Published: 2024-02-12
(Crawled : 12:30)
- prnewswire.com
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
| -29.71%
| O: 0.0%
H: 3.51%
C: -1.11%
cancer
car-t
trial
Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
Published: 2024-01-29
(Crawled : 15:00)
- biospace.com/
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
| -27.63%
| O: -0.23%
H: 6.75%
C: 1.6%
conference
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
Published: 2024-01-23
(Crawled : 13:30)
- biospace.com/
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
| -34.64%
| O: 0.0%
H: 3.09%
C: 1.03%
patent
vaccine
cancer
technology
Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
Published: 2024-01-10
(Crawled : 14:00)
- prnewswire.com
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
| -21.92%
| O: -0.25%
H: 11.85%
C: 9.38%
conference
Anixa Biosciences to Present at Biotech Showcase 2024
Published: 2023-12-14
(Crawled : 12:30)
- prnewswire.com
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
| -18.93%
| O: 0.51%
H: 1.6%
C: -3.31%
biotech
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Published: 2023-12-06
(Crawled : 23:00)
- prnewswire.com
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
| -19.34%
| O: 2.29%
H: 5.63%
C: -10.45%
vaccine
breast
positive
cancer
study
Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Published: 2023-12-06
(Crawled : 21:00)
- prnewswire.com
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
| -19.34%
| O: 2.29%
H: 5.63%
C: -10.45%
conference
vaccine
breast
positive
cancer
ongoing
study
Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Published: 2023-11-27
(Crawled : 13:30)
- prnewswire.com
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
| 7.09%
| O: -0.34%
H: 8.47%
C: 5.08%
patent
vaccine
cancer
technology
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001493152-24-014154
4
2024-04-10
2024-04-09
Buy
P
15009
838037
0001493152-24-010060
4
2024-03-15
2024-03-15
Buy
P
10000
110000
0001493152-24-010028
4
2024-03-15
2024-03-15
Buy
P
30000
491925
0001493152-24-002531
4
2024-01-17
2024-01-12
Buy
A
25000
25000
0001493152-24-002530
4
2024-01-17
2024-01-12
Buy
A
25000
25000